Note 10 - Government Grants and Contracts

3 Months Ended

Mar. 31, 2017

Notes to Financial Statements

Government Grants and Contracts [Text Block]

10.

        Government Grants and Contracts

We receive ongoing payments from government entities under our grants and contracts with the National Institute of Allergy and Infectious Diseases in support of our vaccine research and development efforts. We record revenue associated with government grants and contracts as the reimbursable costs are incurred. During the

three

-month periods ended

March

31,

2017

and

2016,

we recorded

$295,735

and

$47,600,

respectively, of revenues associated with these grants and contracts. As of

March

31,

2017,

there is an aggregate of

$867,911

in approved grant and contract funds available for use.